Patent · US Active

Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

US12414953B2 · kind B2 · utility

0Cited by
0References
70Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2020
Grant dateSep 16, 2025
Priority date—
Expiry dateAug 31, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure is directed to pharmaceutically acceptable salts of the compound of Formula I (I). Pharmaceutical compositions comprising pharmaceutically acceptable salts of the compound of Formula I, as well as methods of their use and preparation, are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.